Skip to content
MarketScale
‹ Back to IndustriesHealthcare

Identifying Key Metrics and Analyzing Data on Performance Gaps Enhance MLR Review Processes

Data-driven analysis of key performance metrics can uncover hidden inefficiencies in MLR (medical, legal, and regulatory) review workflows for life sciences companies. By identifying and closing performance gaps, organizations can convert their compliance review processes from bottlenecks into competitive advantages. EY's approach emphasizes systematic measurement and continuous improvement within promotional material review.

This story was produced through MarketScale. See how Healthcare teams put it to work with Executive Thought Leadership.

By Annalise Ludtke · Jessy HorrellMlr ReviewPromotional Material Review ProcessPromotional Review Data
Share
Identifying Key Metrics and Analyzing Data on Performance Gaps Enhance MLR Review Processes

Key takeaways

01

Tracking the right KPIs in MLR review processes reveals workflow inefficiencies that are otherwise invisible to compliance teams.

02

Analyzing performance gaps enables life sciences companies to streamline promotional material approvals and reduce cycle times.

03

A data-driven MLR review strategy can reframe compliance from a cost center into a source of competitive differentiation.

Leveraging data to refine and enhance the promotional material review (MLR) process has become crucial in the ever-evolving landscape of life sciences. Organizations striving for efficiency and compliance need to understand how best to utilize available data to impact their workflow and overall success significantly.

Organizations striving for efficiency and compliance need to understand how best to utilize available data to impact their workflow and overall success significantly.

How can organizations use data to improve their MLR review processes? What specific metrics and insights should they focus on?

This episode of “Amend & Progress,” Vodori’s go-to podcast for all things promotional material features Jessy Horrell, VP of Customer Success at Vodori. She joins the host of the show, Annalise Ludtke to discuss the real-time analysis of promotional review data, uncovering insights and exploring how organizations can utilize this data to drive process improvements.

Key Points of Discussion

  • High-Level Metrics: Analyzing key performance indicators (KPIs) such as average job duration, feedback incorporation time, and review duration compared to industry benchmarks.
  • Workload Distribution: Understanding the distribution of tasks among reviewers and identifying potential bottlenecks or resource imbalances.
  • Performance Gaps: Identifying bottom performers and discussing strategies for supporting and improving their performance.

Jessy Horrell serves as the VP of Customer Success at Vodori, where she oversees customer onboarding and ongoing success with Vodori’s products. With a data-driven approach, Jessy helps clients understand and utilize their data to make informed decisions and enhance their MLR processes. Jessy holds a degree in Business Administration and has received numerous accolades for her contributions to customer success in the life sciences industry.

About the author

AL
Annalise Ludtke

Healthcare: are you visible to AI?

Before they reach out, Healthcare buyers ask AI engines which vendors to trust. See how AI describes your company today, and where competitors show up instead.

Free workspace

You just read one Healthcare expert. Imagine publishing your whole team.

This article was produced through MarketScale. Create a free workspace and turn your own team's Healthcare expertise into the articles, video, and social content B2B marketing buyers in your industry are searching for. No credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What you get, free

Your own MarketScale Studio workspace
One video edit a month, on us
AI writing, editing, and publishing tools
In-platform coaching to learn the system

More Healthcare Insights

Digital health VC hits $7.4B in H1 2026 as AI agents, chronic care, and workforce tools capture mega-deal capital

Digital health VC hits $7.4B in H1 2026 as AI agents, chronic care, and workforce tools capture mega-deal capital

Digital health venture funding reached $7.4B in the first half of 2026, with significant investments in AI agent platforms and chronic care tools. Mega-deals of over $100 million were a key driver of the funding surge.

  • 01Digital health VC funding hit $7.4 billion in the first half of 2026.
  • 02Mega-deals in AI agent platforms and chronic care tools exceeded $100 million.
  • 03AI, chronic care, and workforce tools dominate digital health investments.

Aug 4, 2026

Pharma M&A surges on a single day: KKR's $5.7B Integer deal, Curium's $8B Lantheus buy, and AstraZeneca's blocked megamerger signal a restructuring market

Pharma M&A surges on a single day: KKR's $5.7B Integer deal, Curium's $8B Lantheus buy, and AstraZeneca's blocked megamerger signal a restructuring market

Three significant transactions occurred in the pharmaceutical and medtech sectors on August 3, highlighting a split M&A market. While mid-market buyouts such as KKR's acquisition of Integer Holdings and Curium's purchase of Lantheus proceeded, larger megamergers like AstraZeneca's faced obstacles. This suggests a trend towards restructuring within the industry.

  • 01KKR acquired Integer Holdings for $5.7 billion.
  • 02Curium purchased Lantheus in an $8 billion deal.
  • 03AstraZeneca's megamerger attempt was blocked.

Aug 3, 2026

CMS centralizes AI and interoperability under a new Office of Health Technology and Products

CMS centralizes AI and interoperability under a new Office of Health Technology and Products

The Centers for Medicare & Medicaid Services (CMS) has established the Office of Health Technology and Products to integrate AI, interoperability, and digital strategies. This new office aims to enhance efficiency across Medicare, Medicaid, and CHIP programs. By centralizing these efforts, CMS seeks to improve healthcare delivery and outcomes.

  • 01The CMS has launched a new office focusing on AI and interoperability.
  • 02The Office of Health Technology and Products will support Medicare, Medicaid, and CHIP programs.
  • 03Centralizing digital strategies aims to improve healthcare delivery and outcomes.

Aug 1, 2026

Explore More Healthcare Insights

Read more expert perspectives from across Healthcare.

Browse Healthcare Hub

About the Expert

AL
Annalise Ludtke

Manager, Life Sciences Regulatory & Compliance at EY

Annalise Ludtke is a manager at EY specializing in life sciences regulatory and compliance. She focuses on optimizing medical, legal, and regulatory (MLR) review processes through data-driven methodologies. Her work helps pharmaceutical and biotech organizations transform compliance workflows into operational advantages.

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Healthcare and beyond.

Book a 15-minute demo

Or call us. No forms required. We pick up. 214-945-2512